BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 22145189)

  • 1. Implementation of the Methamphetamine Production Prevention Act of 2008. Final rule.
    Drug Enforcement Administration (DEA), Justice
    Fed Regist; 2011 Dec; 76(231):74696-9. PubMed ID: 22145189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retail sales of scheduled listed chemical products; self-certification of regulated sellers of scheduled listed chemical products. Interim final rule with request for comment.
    Drug Enforcement Administration (DEA), Justice
    Fed Regist; 2006 Sep; 71(186):56008-27. PubMed ID: 17017470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Removal of thresholds for the List I chemicals pseudoephedrine and phenylpropanolamine. Final rule.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2010 Jul; 75(129):38915-22. PubMed ID: 20608288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementation of the Comprehensive Methamphetamine Control Act of 1996; regulation of pseudoephedrine, phenylpropanolamine, and combination ephedrine drug products and reports of certain transactions to nonregulated persons. Final rule.
    Drug Enforcement Administration (DEA), Justice
    Fed Regist; 2002 Mar; 67(60):14853-62. PubMed ID: 11922057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Information on foreign chain of distribution for ephedrine, pseudoephedrine, and phenylpropanolamine. Final rule.
    Drug Enforcement Administration (DEA), Justice
    Fed Regist; 2010 Mar; 75(43):10168-72. PubMed ID: 20383917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-certification and employee training of mail-order distributors of scheduled listed chemical products. Interim final rule with request for comment.
    Drug Enforcement Administration (DEA), Department of Justice
    Fed Regist; 2011 Apr; 76(71):20518-24. PubMed ID: 21491808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exemption of chemical mixtures containing the List I chemicals ephedrine, N-methylephedrine, N-methylpseudoephedrine, norpseudoephedrine, phenylpropanolamine, and pseudoephedrine. Final rule.
    Drug Enforcement Administration (DEA), Justice
    Fed Regist; 2003 May; 68(84):23195-206. PubMed ID: 12725239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Import and production quotas for certain List I chemicals. Interim final rule with request for comment.
    Drug Enforcement Administration (DEA), Justice
    Fed Regist; 2007 Jul; 72(131):37439-53. PubMed ID: 17674492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elimination of exemptions for chemical mixtures containing the list I chemicals ephedrine and/or pseudoephedrine. Final rule.
    Drug Enforcement Administration (DEA), Department of Justice
    Fed Regist; 2008 Jul; 73(133):39611-4. PubMed ID: 18850676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Registration requirements for importers and manufacturers of prescription drug products containing ephedrine, pseudoephedrine, or phenylpropanolamine. Final rule.
    Drug Enforcement Administration (DEA), Justice
    Fed Regist; 2010 Feb; 75(20):4973-82. PubMed ID: 20352663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementation of the Methamphetamine Anti-Proliferation Act; thresholds for retailers and for distributors required to submit mail order reports; changes to mail order reporting requirements. Final rule.
    Drug Enforcement Administration (DEA), Justice
    Fed Regist; 2003 Oct; 68(194):57799-804. PubMed ID: 14535265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of red phosphorus, white phosphorus and hypophosphorous acid (and its salts) as list I chemicals; exclusions and waivers. Final rule.
    Drug Enforcement Administration (DEA), Justice
    Fed Regist; 2003 Jun; 68(121):37411-4. PubMed ID: 12836650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exemption of chemical mixtures. Final rule.
    Drug Enforcement Administration (DEA), U.S. Department of Justice
    Fed Regist; 2007 Mar; 72(47):10925-8. PubMed ID: 17450656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Listed chemicals; establishment of non-regulated transactions in anhydrous hydrogen chloride. Final rule confirmation.
    Drug Enforcement Administration (DEA), Justice
    Fed Regist; 2001 Aug; 66(159):42944-6. PubMed ID: 11757558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in the regulation of iodine crystals and chemical mixtures containing over 2.2 percent iodine. Final rule.
    Drug Enforcement Administration (DEA), Justice
    Fed Regist; 2007 Jul; 72(126):35920-31. PubMed ID: 17910137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restricting the sale of pseudoephedrine to prevent methamphetamine production.
    Colker AC
    NCSL Legisbrief; 2005 Feb; 13(7):1-2. PubMed ID: 15726724
    [No Abstract]   [Full Text] [Related]  

  • 17. Impacts of federal precursor chemical regulations on methamphetamine arrests.
    Cunningham JK; Liu LM
    Addiction; 2005 Apr; 100(4):479-88. PubMed ID: 15784062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Special surveillance list of chemicals, products, materials and equipment used in the clandestine production of controlled substances or listed chemicals. Drug Enforcement Administration (DEA), Justice. Final notice.
    Fed Regist; 1999 May; 64(92):25910-2. PubMed ID: 10558537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exempt chemical mixtures containing gamma-butyrolactone. Final rule.
    Drug Enforcement Administration (DEA), Justice
    Fed Regist; 2010 Jun; 75(124):37301-7. PubMed ID: 20608286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allowing central fill pharmacies and retail pharmacies to fill prescriptions for controlled substances on behalf of retail pharmacies. Final rule.
    Drug Enforcement Administration (DEA), Justice
    Fed Regist; 2003 Jun; 68(121):37405-11. PubMed ID: 12836645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.